The future of active targeting in nanotechnology is promising. Ongoing research is focused on improving the precision and efficiency of targeting mechanisms. Advancements in CRISPR technology and Artificial Intelligence are expected to play a significant role in designing more effective and personalized therapies. Additionally, the integration of Multifunctional Nanoparticles that can diagnose and treat diseases simultaneously is an exciting area of development.
